• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在荷兰社区药店中使用即时肾护理测试来预防抗生素相关住院的预算影响分析。

Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations.

机构信息

Asc Academics, Westerhaven 13, 9718 AW, Groningen, The Netherlands.

Department of Nephrology, University of Groningen, University Medical Center Groningen (UMCG), Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.

出版信息

Appl Health Econ Health Policy. 2019 Feb;17(1):55-63. doi: 10.1007/s40258-018-0426-2.

DOI:10.1007/s40258-018-0426-2
PMID:30175396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6345725/
Abstract

OBJECTIVES

Medication errors that lead to adverse drug reactions are a key cause of unintentional patient harm and subsequent economic burden. To prevent this, measurement of renal function could be considered. The aim of this study was to determine the budget impact of obtaining and evaluating renal function in community pharmacies in the Netherlands to prevent antibiotic-related hospitalizations.

METHODS

A decision model was built to simulate the process of antibiotic prescriptions in community pharmacies with and without the use of a point-of-care test (PoCT) in patients aged 65 years and older. By using a PoCT, the number of patients with renal function values available increases, leading to the possibility of dose adjustment when necessary. In turn, this might avoid hospitalizations. For this study, real-life patient data were used from 351 community pharmacies. Direct costs of renal function screening, antibiotic treatments, and medical care due to antibiotic-related hospitalization were included.

RESULTS

The budget impact analysis showed annual cost-savings of €86 per patient through the availability of renal function values in Dutch community pharmacies. Savings were mostly due to avoided hospitalizations.

CONCLUSION

Obtaining and evaluating renal function in community pharmacies by point of care tests is expected to be cost-saving in the Netherlands.

摘要

目的

导致药物不良反应的用药错误是造成非故意患者伤害和后续经济负担的一个主要原因。为此,可以考虑对肾功能进行测量。本研究旨在确定在荷兰社区药房获取和评估肾功能以预防与抗生素相关的住院治疗的预算影响。

方法

建立了一个决策模型来模拟社区药房中抗生素处方的处理过程,同时考虑了是否使用即时检测(Point-of-care Test,PoCT)。通过使用 PoCT,肾功能值可用的患者数量增加,从而在必要时可以进行剂量调整,进而避免住院治疗。在这项研究中,使用了 351 家社区药房的真实患者数据。包括肾功能筛查、抗生素治疗和因抗生素相关住院治疗而产生的医疗费用的直接成本。

结果

通过在荷兰社区药房获得肾功能值,预算影响分析显示每位患者每年可节省 86 欧元。节省主要归因于避免了住院治疗。

结论

在荷兰,通过即时检测在社区药房中获取和评估肾功能有望节省成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd7a/6345725/b7b7c9490cb7/40258_2018_426_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd7a/6345725/5c9159a05e5c/40258_2018_426_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd7a/6345725/53addee536ce/40258_2018_426_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd7a/6345725/b7b7c9490cb7/40258_2018_426_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd7a/6345725/5c9159a05e5c/40258_2018_426_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd7a/6345725/53addee536ce/40258_2018_426_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd7a/6345725/b7b7c9490cb7/40258_2018_426_Fig3_HTML.jpg

相似文献

1
Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations.在荷兰社区药店中使用即时肾护理测试来预防抗生素相关住院的预算影响分析。
Appl Health Econ Health Policy. 2019 Feb;17(1):55-63. doi: 10.1007/s40258-018-0426-2.
2
Clinical Decision Support and Optional Point of Care Testing of Renal Function for Safe Use of Antibiotics in Elderly Patients: A Retrospective Study in Community Pharmacy Practice.临床决策支持与肾功能的即时检验用于老年患者安全使用抗生素:社区药房实践的一项回顾性研究
Drugs Aging. 2017 Nov;34(11):851-858. doi: 10.1007/s40266-017-0497-z.
3
Nature, frequency and determinants of prescription modifications in Dutch community pharmacies.荷兰社区药房处方修改的性质、频率及决定因素。
Br J Clin Pharmacol. 2001 Jul;52(1):85-91. doi: 10.1046/j.0306-5251.2001.01406.x.
4
Interventions and documentation for drug-related problems in Dutch community pharmacies.荷兰社区药房中与药物相关问题的干预措施及记录
Am J Health Syst Pharm. 2001 Aug 1;58(15):1428-31. doi: 10.1093/ajhp/58.15.1428.
5
Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis.醋酸乌利司他用于荷兰育龄期女性中重度子宫肌瘤的术前治疗:成本最小化分析和预算影响分析
J Med Econ. 2017 Mar;20(3):280-287. doi: 10.1080/13696998.2016.1254090. Epub 2016 Nov 11.
6
Availability of information on renal function in Dutch community pharmacies.荷兰社区药房中肾功能信息的可获取性。
Int J Clin Pharm. 2016 Aug;38(4):797-801. doi: 10.1007/s11096-016-0332-3. Epub 2016 Jun 15.
7
Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands.噻托溴铵-奥达特罗固定剂量复方支气管扩张剂对荷兰慢性阻塞性肺疾病患者的成本效益及预算影响
Int J Chron Obstruct Pulmon Dis. 2016 Sep 19;11:2191-2201. doi: 10.2147/COPD.S114738. eCollection 2016.
8
Development of a comprehensive community pharmacy patient intake form compliant with OBRA'90 requirements.制定一份符合《1990年综合预算调节法》要求的全面的社区药房患者登记表。
J Pharm Pract. 2011 Oct;24(5):480-4. doi: 10.1177/0897190011415688. Epub 2011 Aug 15.
9
Laboratory testing in pharmacies.药房的实验室检测。
Clin Chem Lab Med. 2010 Jul;48(7):943-53. doi: 10.1515/CCLM.2010.184.
10

引用本文的文献

1
[Detection of nephrotoxics and dose adjustment in patients with low glomerular filtration rate in community pharmacy: methodology].[社区药房中肾小球滤过率低的患者肾毒性检测及剂量调整:方法学]
Farm Comunitarios. 2023 Oct 10;15(4):37-44. doi: 10.33620/FC.2173-9218.(2023).29. eCollection 2023 Oct 16.
2
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally.激励新型抗生素和诊断试剂进入市场的定价、采购和报销政策:全球 10 个国家的经验教训。
Appl Health Econ Health Policy. 2024 Sep;22(5):629-652. doi: 10.1007/s40258-024-00888-y. Epub 2024 Jun 5.
3

本文引用的文献

1
Clinical Decision Support and Optional Point of Care Testing of Renal Function for Safe Use of Antibiotics in Elderly Patients: A Retrospective Study in Community Pharmacy Practice.临床决策支持与肾功能的即时检验用于老年患者安全使用抗生素:社区药房实践的一项回顾性研究
Drugs Aging. 2017 Nov;34(11):851-858. doi: 10.1007/s40266-017-0497-z.
2
Availability of information on renal function in Dutch community pharmacies.荷兰社区药房中肾功能信息的可获取性。
Int J Clin Pharm. 2016 Aug;38(4):797-801. doi: 10.1007/s11096-016-0332-3. Epub 2016 Jun 15.
3
AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.
Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.
社区药房中慢性肾脏病患者的药学监护计划:检测肾毒性药物和剂量调整。可行性研究。
PLoS One. 2022 Dec 22;17(12):e0278648. doi: 10.1371/journal.pone.0278648. eCollection 2022.
4
Creatinine standardization: a key consideration in evaluating whole blood creatinine monitoring systems for CKD screening.肌氨酸酐标准化:评估全血肌氨酸酐监测系统用于 CKD 筛查的关键考虑因素。
Anal Bioanal Chem. 2022 Apr;414(10):3279-3289. doi: 10.1007/s00216-022-03942-7. Epub 2022 Mar 9.
5
Health Economic Evidence of Point-of-Care Testing: A Systematic Review.即时检验的卫生经济学证据:一项系统综述。
Pharmacoecon Open. 2021 Jun;5(2):157-173. doi: 10.1007/s41669-020-00248-1. Epub 2021 Jan 6.
AdViSHE:面向决策者和模型使用者的健康经济模型验证评估工具。
Pharmacoeconomics. 2016 Apr;34(4):349-61. doi: 10.1007/s40273-015-0327-2.
4
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.预算影响分析——良好实践原则:ISPOR 2012 预算影响分析良好实践 II 工作组报告。
Value Health. 2014 Jan-Feb;17(1):5-14. doi: 10.1016/j.jval.2013.08.2291. Epub 2013 Dec 13.
5
Feasibility of point-of-care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients.在社区药房进行即时肌酐检测以监测门诊老年患者药物治疗的可行性。
J Clin Pharm Ther. 2013 Oct;38(5):416-22. doi: 10.1111/jcpt.12081. Epub 2013 Jun 28.
6
Optimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: improving drug safety in primary healthcare by low eGFR alerts.优化因肾功能损害而有药物错误风险的患者的药物处方和配药:通过低 eGFR 警报改善初级保健中的药物安全性。
BMJ Open. 2013 Jan 24;3(1):e002068. doi: 10.1136/bmjopen-2012-002068.
7
Contribution of renal impairment to potentially preventable medication-related hospital admissions.肾功能损害对潜在可预防的药物相关住院的影响。
Ann Pharmacother. 2012 May;46(5):625-33. doi: 10.1345/aph.1Q633. Epub 2012 May 8.
8
Pharmacokinetics and dosage adjustment in patients with renal dysfunction.肾功能不全患者的药代动力学与剂量调整
Eur J Clin Pharmacol. 2009 Aug;65(8):757-73. doi: 10.1007/s00228-009-0678-8. Epub 2009 Jun 20.
9
A new equation to estimate glomerular filtration rate.一种估算肾小球滤过率的新公式。
Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006.
10
Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.荷兰可预防的药物相关住院情况的发生率及风险因素
Arch Intern Med. 2008 Sep 22;168(17):1890-6. doi: 10.1001/archinternmed.2008.3.